ACTINIUM PHARMACEUTICALS, INC. Gain (Loss) on Disposition of Property (Deprecated 2013-01-31)
ACTINIUM PHARMACEUTICALS, INC. (ATNM) reported Gain (Loss) on Disposition of Property (Deprecated 2013-01-31) of -$4.12 thousand for the 3-month period ending 2013-03-31, per its 10-Q filed 2013-05-15.
Discontinued › Income Statement › Other Income
us-gaap:GainLossOnDispositionOfProperty · last filed 2013-05-15
- ACTINIUM PHARMACEUTICALS, INC. gain (loss) on disposition of property (deprecated 2013-01-31) for the quarter ending 2013-03-31 was -$4.12K.
| Period end | Gain (Loss) on Disposition of Property (Deprecated 2013-01-31) 3 month | Gain (Loss) on Disposition of Property (Deprecated 2013-01-31) 151 month | Gain (Loss) on Disposition of Property (Deprecated 2013-01-31) 154 month |
|---|---|---|---|
| 2013-03-31 | -$4.12K 10-Q · filed 2013-05-15 | -$554.31K 10-Q · filed 2013-05-15 | |
| 2012-12-31 | -$550.19K 10-K · filed 2013-03-29 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| FILANA THERAPEUTICS, INC. (FLNA) | United States | $0.038B | -1.05 |
| PMGC Holdings Inc. (ELAB) | United States | $0.037B | |
| Celularity Inc (CELU) | United States | $0.038B | -0.34 |
| CervoMed Inc. (CRVO) | United States | $0.038B | -1.39 |
| BriaCell Therapeutics Corp. (BCTX) | $0.037B | ||
| Edesa Biotech, Inc. (EDSA) | Canada | $0.039B | |
| Seres Therapeutics, Inc. (MCRB) | United States | $0.036B | -3.45 |
| MIRA PHARMACEUTICALS, INC. (MIRA) | United States | $0.036B | -4.30 |
| Karyopharm Therapeutics Inc. (KPTI) | United States | $0.039B | -0.98 |
| Incannex Healthcare Inc. (IXHL) | $0.040B | -22.32 |